Leishmania donovani Growth Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture.
Markos TadeleSolomon Mequanente AbayEyasu MakonnenAsrat HailuPublished in: Drug design, development and therapy (2020)
The current study indicates the presence of additional hits which may hold promise as starting points for anti-leishmanial drug discovery and in-depth structure-activity relationship studies.